Ysios Capital
Ysios Capital is a leading European venture capital firm focused on life sciences. They invest globally in biotech ventures developing novel therapeutic drugs, supporting companies through preclinical and clinical development. Their investment thesis prioritizes strong scientific foundations, exceptional teams, and indications with high unmet medical needs.
SpainAcendo, AELIX Therapeutics, AM Pharma, Anaconda Biomed, Aura Biosciences, Babyscripts, BioVex, CorWave, CVRx, Cytoki Pharma, EndoSense, Engrail Therapeutics, Fusion Pharmaceuticals, Galecto Biotech, Inbiomotion, KALA BIO, Kynexis, LAVA Therapeutics, MedLumics, Memo Therapeutics, Mineralys Therapeutics, Minoryx Therapeutics, Neurona Therapeutics, Northsea Therapeutics, Ona Therapeutics, OxThera, Prexton Therapeutics, Sanifit, SparingVision, SpliceBio, STAT Dx, Synendos, Tagworks Pharmaceuticals, TiGenix, VarmX, Vivet Therapeutics, Xeltis